White label – Pompe disease - ClinicalTrials.eu

Safety Study of Sonrotoclax and Zanubrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

Recruiting

1 1 1
Investigated Diseases:
- Mantle cell lymphoma recurrent
- Mantle cell lymphoma refractory
Investigated Drugs:
- N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
- Zanubrutinib
Study of mRNA-4157 and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Bladder cancer
Investigated Drugs:
- Mrna-4157
+3
Study of Tarlatamab for Patients with Metastatic or Advanced Small-Cell Lung Cancer and Neuroendocrine Carcinomas

Recruiting

2 1 1
Investigated Diseases:
- Small cell lung cancer metastatic
- Neuroendocrine carcinoma
Investigated Drugs:
- Tarlatamab
Study on IV NEPA (Fosnetupitant/Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients

Recruiting

4 1 1
Investigated Diseases:
- Prophylaxis of nausea and vomiting
Investigated Drugs:
Study on Sotatercept for Improving Heart Function in Patients with Pulmonary Arterial Hypertension

Recruiting

3 1 1 1
Investigated Drugs:
- Sotatercept
Study of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer

Recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2
- Pembrolizumab
+1
Study on Cemiplimab and OSE2101 for Maintenance Therapy in Patients with ctDNA Positive Non-Small Cell Lung Cancer (NSCLC)

Recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn’s Disease

Recruiting

3 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- Ro7790121
+10
Study on Rezafungin Levels in Critically Ill Patients with Invasive Candidiasis Undergoing ECMO or RRT

Recruiting

3 1 1 1
Investigated Diseases:
- Candida infection
- Systemic candida
Investigated Drugs:
- Rezafungin Acetate
Study on IMA203 for Patients with Previously Treated Unresectable or Metastatic Skin Melanoma

Recruiting

3 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies